Disclosures for "Efficacy and Safety of Fremanezumab in Patients with Migraine and Obesity: Post Hoc Analysis of the Phase 3 HALO-LTS and FOCUS Clinical Trials"
-
Dr. Irimia Sieira has received personal compensation for serving as an employee of TEVA. Dr. Irimia Sieira has received personal compensation for serving as an employee of Lundbeck. Dr. Irimia Sieira has received personal compensation for serving as an employee of Eli Lilly. Dr. Irimia Sieira has received personal compensation for serving as an employee of Pfizer. Dr. Irimia Sieira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Irimia Sieira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie.
-
Brad Torphy has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Brad Torphy has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Impel. Brad Torphy has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Brad Torphy has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Brad Torphy has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Abbvie. Brad Torphy has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Amgen. Brad Torphy has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven. Brad Torphy has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Impel. Brad Torphy has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Lilly. Brad Torphy has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck. Brad Torphy has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Teva. The institution of Brad Torphy has received research support from Amgen. The institution of Brad Torphy has received research support from Teva. The institution of Brad Torphy has received research support from Theranica. The institution of Brad Torphy has received research support from Abbvie.
-
Dr. Ortega has received personal compensation for serving as an employee of Teva Pharmaceuticals.
-
Dr. Barash has received personal compensation for serving as an employee of Teva. Dr. Barash has stock in Teva.
-
Lynda Krasenbaum has received personal compensation for serving as an employee of Teva Pharmaceuticals.
-
Dr. Akcicek has received personal compensation for serving as an employee of Teva Pharmaceuticals.
-
Mrs. Smith has nothing to disclose.
-
Ms. Ning has received personal compensation for serving as an employee of Teva Pharmaceutical . Ms. Ning has received personal compensation for serving as an employee of Teva Pharmaceutical.
-
Dr. Ramirez Campos has received personal compensation for serving as an employee of teva.